Particle Size Analysis Market worth $596 million by 2028
- rp4258723
- Feb 26
- 4 min read
Particle Size Analysis Market in terms of revenue was estimated to be worth $446 million in 2023 and is poised to reach $596 million by 2028, growing at a CAGR of 6.0% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. Market growth is attributed to the Escalating investments in research and development within the pharmaceutical sector, driving market expansion.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833
Based on the technology, the particle size analysis market is segmented into laser diffraction, dynamic light scattering, imaging, coulter principle, nanoparticle tracking analysis, sieve analysis, and other technologies. The nanoparticle tracking analysis (NTA) technology segment is expected to witness the highest growth rate during the forecast period 2023 to 2028. The advanced capabilities provided by NTA find primary application in the biopharmaceutical and biotechnology sectors. The growing research and development efforts within the biopharmaceutical industry underscores the expanding utility of this technology.
Based on dispersion type, the particle size analysis market is segmented into wet dispersion, dry dispersion, and spray dispersion. Wet dispersion segment is expected to register the highest growth rate during the forecast period 2023 to 2028. The substantial growth rate in this market segment is primarily driven by the expanding range of applications for nanoparticles, predominantly assessed through liquid dispersion methods.
Based on type, the particle size analysis market is segmented into the particle size analysis market is further segmented further into bench-top analyzers and portable analyzers. Bench- top analyzer is expected to register the highest growth rate during the forecast period 2023 to 2028. High levels of efficacy and adaptability are evident in a variety of applications, including point-of-care diagnostics, pharmaceutical research, environmental analysis, food safety, material science, biotechnology, cannabis testing, and the characterization of nanomaterials are expected to be key drivers of market growth.
Based on end users, the particle size analysis market is segmented into healthcare industry, cosmetic industry, chemical and petroleum industry, mining, minerals, and cement industry, food and beverage industry, other industries (include industries related to inks, toners, paints, coatings, and environmental analysis, among others. The healthcare industry is expected to register the highest growth rate during the forecast period 2023 to 2028. The growing utilization of nanotechnology in the realm of medical science, the surging expansion of pharmaceuticals within the healthcare sector, and the rising prevalence of analytical laboratories all mark notable developments are expected to be key drivers of market growth.
Based on region, the particle size analysis industry is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America particle size analysis market is anticipated to register the highest growth during the forecast period 2023 to 2028. The growing government backing for nanotechnology research and the escalating proliferation of stringent regulatory standards regarding product quality within the pharmaceutical and food & beverage sectors are major factors responsible for the growth of the market.
Buy a Particle Size Analysis Industry Report (204 Pages PDF with Insightful Charts, Tables, and Figures):https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=74084833
Particle Size Analysis market major players covered in the report, such as:
Spectris (UK),
HORIBA (Japan),
Danaher (US),
Anton Paar GmbH (Austria),
Bettersize Instruments Ltd. (China),
Brookhaven Instruments (US),
Fritsch GmbH (Germany),
LS Instruments (Switzerland),
Metller Toledo (US),
Micromeritics Instrument Corporation (US),
Microtrac Retsch GmbH (Germany),
Sympatec GmbH (Germany),
TSI (US),
and Among Others
Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=74084833
This report has segmented the particle size analysis market based on technology, dispersion, type, end-user, and region.
Particle Size Analysis Market, by Technology
Laser Diffraction
Dynamic Light scattering
Imaging
Dynamic Imaging
Static Imaging
Nanoparticle Tracking Analysis (NTA)
Coulter Principle
Sieve Analysis
Other Technologies
Particle Size Analysis Market, by Dispersion
Wet Dispersion
Dry Dispersion
Spray Dispersion
Particle Size Analysis Market, by Type
Bench-Top Analyzers
Portable Analyzers
Particle Size Analysis Market, by End User
Healthcare Industry
Pharmaceutical & Biotechnology Companies
Public & Private Institutions
Academic Institutions
Cosmetic Industry
Chemicals & Petroleum Industry
Mining, Minerals and Cement Industry
Food & Beverage Industry
Other Industries
Particle Size Analysis Market, by Region
North America
US
Canada
Europe
Germany
France
UK
Spain
Italy
Rest of Europe
Asia Pacific
Japan
China
India
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=74084833
Recent Developments
In August 2023, Anton Paar GmbH introduced Litesizer DIA 500, the latest addition to the Particle Analysis & Surface Charge (PC) product line. This innovative instrument brings dynamic image analysis to your fingertips, allowing for precise measurement of particle size and shape within the range of 0.8 µm to 8,000 µm. With 1 µm equaling 0.001 millimeter.
In May 2023, The Verder Group has acquired France’s Formulaction S.A. and will integrate it into Microtrac MRB, a prominent manufacturer of Particle Characterization Systems within the group’s Scientific Division.
In March 2022, Aerolase is expanding its services beyond aesthetic treatments to help dermatologists with different focuses. They will now offer treatments for conditions like vitiligo, leukoderma, and atopic dermatitis. They’re also working on getting FDA clearance for treating alopecia areata in 2023, using technology that has already been proven effective in Europe and other places. These additions will complement their existing treatments for acne, psoriasis, and rosacea.
Comments